Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/05/2020 08/06/2020 08/07/2020 08/10/2020 08/11/2020 Date
102.14(c) 101.75(c) 101.23(c) 100.04(c) 99.06(c) Last
4 416 036 3 942 990 3 141 906 2 776 738 4 823 354 Volume
+2.21% -0.38% -0.51% -1.18% -0.98% Change
More quotes
Financials (USD)
Sales 2020 32 812 M - -
Net income 2020 3 903 M - -
Net Debt 2020 12 104 M - -
P/E ratio 2020 45,2x
Yield 2020 1,47%
Sales 2021 36 053 M - -
Net income 2021 4 937 M - -
Net Debt 2021 9 596 M - -
P/E ratio 2021 35,8x
Yield 2021 1,59%
Capitalization 175 B 175 B -
EV / Sales 2020 5,71x
EV / Sales 2021 5,13x
Nbr of Employees 107 000
Free-Float 88,8%
More Financials
Company
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (38.4%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (24.2%); - nutrition products (23.2%): pediatric nutrition products, nutritional supplements, and... 
More about the company
Surperformance© ratings of Abbott Laboratories
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBOTT LABORATORIES
08/04ABBOTT : Announces Start of Study to Evaluate New Device to Treat Recurrent Atri..
PR
07/29ABBOTT LABORATORIES : Management's Discussion and Analysis of Financial Conditio..
AQ
07/27The U.S. has more COVID-19 testing than most. So why is it falling so short?
RE
07/23ABBOTT : Receives FDA Approval for iOS-Compatible App Allowing People Living Wit..
PR
07/22GLOBAL MARKETS LIVE: Snap, Microsoft, Tesla…
07/21Health Care Up On Covid Treatment Hopes -- Health Care Roundup
DJ
07/17ABBOTT LABORATORIES : Reports second-quarter 2020 results, exceeds analysts expe..
AQ
07/17Abbott Gets Lift From Virus Tests -- WSJ
DJ
07/16NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/16NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/16Health Care Down As More Vaccine Data Awaited -- Health Care Roundup
DJ
07/16NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/16Abbott Laboratories Gets Boost From U.S. Covid-19 Testing -- 2nd Update
DJ
07/16NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/16Abbott CEO Says "It's Clear That The Need For Testing Is Large And It Isn't G..
RE
More news
News in other languages on ABBOTT LABORATORIES
08/04ABBOTT : Announces Start of Study to Evaluate New Device to Treat Recurrent Atri..
07/29ABBOTT LABORATORIES : Management's Discussion and Analysis of Financial Conditio..
07/27The U.S. has more COVID-19 testing than most. So why is it falling so short?
07/23ABBOTT : Receives FDA Approval for iOS-Compatible App Allowing People Living Wit..
07/22GLOBAL MARKETS LIVE: Snap, Microsoft, Tesla…
More news
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 105,94 $
Last Close Price 99,06 $
Spread / Highest target 26,2%
Spread / Average Target 6,95%
Spread / Lowest Target -19,2%
EPS Revisions
Managers
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES14.05%177 124
MEDTRONIC PLC-11.52%134 640
BECTON, DICKINSON AND COMPANY-5.60%74 424
BAXTER INTERNATIONAL INC.-0.62%42 068
DEXCOM, INC.92.57%40 329
HOYA CORPORATION-1.91%36 646